K-877
As of the edition of 20 October 2026, K-877 is a drug: stopped in 2022; acts on PPARA.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2022
- Kind
- Unknown
- Registered trials
- 17, 1 stopped early
- Disease areas
- Nutrition and metabolism; Digestive system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 11 | 11 | 0 | 0 |
| Phase 2 | 2 | 2 | 0 | 0 |
| Phase 3 | 4 | 3 | 0 | 1 |
| All trials | 17 |